B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes

Damle RN, Ghiotto F, Valetto A, Albasiano E, Fais F, Yan XJ, Sison CP, Allen SL, Kolitz J, Schulman P, Vinciguerra VP, et al. (2002)
BLOOD 99(11): 4087-4093.

Download
No fulltext has been uploaded. References only!
Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ; ; ; ; ; ;
All
Abstract
B-cell chronic lymphocytic leukemia (B-CLL) is considered an accumulative disease of antigen-naive CD5(+) B lymphocytes that circulate in the resting state. However, to evaluate the possibility that B-CLL cells resemble antigen-experienced and activated B cells, we analyzed the expression of markers of cellular activation and differentiation on CD5(+)CD19(+) cells from B-CLL patients and from age-matched healthy donors. The leukemic cells from all B-CLL patients, including those that lack significant numbers of V gene mutations, bear the phenotype of activated B cells based on the overexpression of the activation markers CD23, CD25, CD69, and CD71 and the underexpression of CD22, Fcgamma receptor IIb, CD79b, and immunoglobulin D that are down-regulated by cell triggering and activation. Furthermore, these leukemic cells resemble antigen-experienced lymphocytes in the underexpression of molecules that are down-regulated by cell triggering and in the uniform expression of CD27, an identifier of memory B cells. A comparison of the phenotypes of B-CLL patients with and without immunoglobulin V gene mutations suggests that the 2 subgroups differ both in specific marker expression (CD69, CD71, CD62 L, CD40, CD39, and HLA-DR) and in the time since antigenic stimulation, based on the reciprocal relationship of CD69 and CD71 expression. These findings imply that the leukemic cells from all B-CLL cases (irrespective of V gene mutations) exhibit features of activated and of antigen-experienced B lymphocytes and that the B-CLL cells that differ in immunoglobulin V genotype may have different antigen-encounter histories. (C) 2002 by The American Society of Hematology.
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Damle RN, Ghiotto F, Valetto A, et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. BLOOD. 2002;99(11):4087-4093.
Damle, R. N., Ghiotto, F., Valetto, A., Albasiano, E., Fais, F., Yan, X. J., Sison, C. P., et al. (2002). B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. BLOOD, 99(11), 4087-4093. doi:10.1182/blood.V99.11.4087
Damle, R. N., Ghiotto, F., Valetto, A., Albasiano, E., Fais, F., Yan, X. J., Sison, C. P., Allen, S. L., Kolitz, J., Schulman, P., et al. (2002). B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. BLOOD 99, 4087-4093.
Damle, R.N., et al., 2002. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. BLOOD, 99(11), p 4087-4093.
R.N. Damle, et al., “B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes”, BLOOD, vol. 99, 2002, pp. 4087-4093.
Damle, R.N., Ghiotto, F., Valetto, A., Albasiano, E., Fais, F., Yan, X.J., Sison, C.P., Allen, S.L., Kolitz, J., Schulman, P., Vinciguerra, V.P., Budde, P., Frey, J., Rai, K.R., Ferrarini, M., Chiorazzi, N.: B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. BLOOD. 99, 4087-4093 (2002).
Damle, RN, Ghiotto, F, Valetto, A, Albasiano, E, Fais, F, Yan, XJ, Sison, CP, Allen, SL, Kolitz, J, Schulman, P, Vinciguerra, VP, Budde, P, Frey, Jürgen, Rai, KR, Ferrarini, M, and Chiorazzi, N. “B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes”. BLOOD 99.11 (2002): 4087-4093.
This data publication is cited in the following publications:
This publication cites the following data publications:

160 Citations in Europe PMC

Data provided by Europe PubMed Central.

Lamin B1 regulates somatic mutations and progression of B-cell malignancies.
Klymenko T, Bloehdorn J, Bahlo J, Robrecht S, Akylzhanova G, Cox K, Estenfelder S, Wang J, Edelmann J, Strefford JC, Wojdacz TK, Fischer K, Hallek M, Stilgenbauer S, Cragg M, Gribben J, Braun A., Leukemia 32(2), 2018
PMID: 28804121
CD11c expression in chronic lymphocytic leukemia revisited, related with complications and survival.
Umit EG, Baysal M, Durmus Y, Demir AM., Int J Lab Hematol 39(5), 2017
PMID: 28603911
FcγRIIb expression in early stage chronic lymphocytic leukemia.
Bosch R, Mora A, Vicente EP, Ferrer G, Jansa S, Damle R, Gorlatov S, Rai K, Montserrat E, Nomdedeu J, Pratcorona M, Blanco L, Saavedra S, Garrido A, Esquirol A, Garcia I, Granell M, Martino R, Delgado J, Sierra J, Chiorazzi N, Moreno C., Leuk. Lymphoma 58(11), 2017
PMID: 28372509
Dynamic variation of CD5 surface expression levels within individual chronic lymphocytic leukemia clones.
Bashford-Rogers RJ, Palser AL, Hodkinson C, Baxter J, Follows GA, Vassiliou GS, Kellam P., Exp. Hematol. 46(), 2017
PMID: 27693386
Ectonucleoside triphosphate diphosphohydrolase-1 (E-NTPDase1/CD39) as a new prognostic marker in chronic lymphocytic leukemia.
Abousamra NK, Salah El-Din M, Hamza Elzahaf E, Esmael ME., Leuk. Lymphoma 56(1), 2015
PMID: 24684231
Atomic force microscopy of chronic lymphatic leukaemia cells activation induced by Staphylococcus aureus.
Dong S, Wang Q, Sun S, Liang Y, Jiang J, Liu L, Hu A, Cai J., Cell Biol. Int. 37(4), 2013
PMID: 23450797
Chronic lymphocytic leukemia: new concepts and emerging therapies.
Ahmadi T, Maniar T, Schuster S, Stadtmauer E., Curr Treat Options Oncol 10(1-2), 2009
PMID: 19169831
CD5 links humoral autoimmunity with B-cell chronic lymphocytic leukemia.
Mankai A, Bordron A, Renaudineau Y, Berthou C, Ghedira I, Youinou P., Expert Rev Clin Immunol 3(3), 2007
PMID: 20477677

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 12010811
PubMed | Europe PMC

Search this title in

Google Scholar